165 related articles for article (PubMed ID: 10831352)
1. Prognostic significance of vascular endothelial growth factor and its receptors in endometrial carcinoma.
Yokoyama Y; Sato S; Futagami M; Fukushi Y; Sakamoto T; Umemoto M; Saito Y
Gynecol Oncol; 2000 Jun; 77(3):413-8. PubMed ID: 10831352
[TBL] [Abstract][Full Text] [Related]
2. VEGF, flt-1, and KDR/flk-1 as prognostic indicators in endometrial carcinoma.
Fine BA; Valente PT; Feinstein GI; Dey T
Gynecol Oncol; 2000 Jan; 76(1):33-9. PubMed ID: 10620438
[TBL] [Abstract][Full Text] [Related]
3. Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) in esophageal squamous cell carcinoma.
Kato H; Yoshikawa M; Miyazaki T; Nakajima M; Fukai Y; Masuda N; Fukuchi M; Manda R; Tsukada K; Kuwano H
Anticancer Res; 2002; 22(6C):3977-84. PubMed ID: 12553021
[TBL] [Abstract][Full Text] [Related]
4. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in endometrial carcinoma.
Guidi AJ; Abu-Jawdeh G; Tognazzi K; Dvorak HF; Brown LF
Cancer; 1996 Aug; 78(3):454-60. PubMed ID: 8697391
[TBL] [Abstract][Full Text] [Related]
5. [Correlation of angiogenesis with expression of vascular endothelial growth factor and its receptors in lung carcinoma].
Zhang G; Zhao M; Xu M; Yang Y; Wang M; Yang C
Zhonghua Jie He He Hu Xi Za Zhi; 2002 Feb; 25(2):89-93. PubMed ID: 11953105
[TBL] [Abstract][Full Text] [Related]
6. Expression of vascular endothelial growth factor (VEGF)-D and its receptor, VEGF receptor 3, as a prognostic factor in endometrial carcinoma.
Yokoyama Y; Charnock-Jones DS; Licence D; Yanaihara A; Hastings JM; Holland CM; Emoto M; Sakamoto A; Sakamoto T; Maruyama H; Sato S; Mizunuma H; Smith SK
Clin Cancer Res; 2003 Apr; 9(4):1361-9. PubMed ID: 12684405
[TBL] [Abstract][Full Text] [Related]
7. VEGF and VEGF type C play an important role in angiogenesis and lymphangiogenesis in human malignant mesothelioma tumours.
Ohta Y; Shridhar V; Bright RK; Kalemkerian GP; Du W; Carbone M; Watanabe Y; Pass HI
Br J Cancer; 1999 Sep; 81(1):54-61. PubMed ID: 10487612
[TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor-D expression is an independent prognostic marker for survival in colorectal carcinoma.
White JD; Hewett PW; Kosuge D; McCulloch T; Enholm BC; Carmichael J; Murray JC
Cancer Res; 2002 Mar; 62(6):1669-75. PubMed ID: 11912138
[TBL] [Abstract][Full Text] [Related]
9. [Expression and clinical significance of VEGF and its receptors Flt-1 and KDR in nasopharyngeal carcinoma].
Sha D; He YJ
Ai Zheng; 2006 Feb; 25(2):229-34. PubMed ID: 16480593
[TBL] [Abstract][Full Text] [Related]
10. Association of hypoxia-inducible factors 1alpha and 2alpha with activated angiogenic pathways and prognosis in patients with endometrial carcinoma.
Sivridis E; Giatromanolaki A; Gatter KC; Harris AL; Koukourakis MI;
Cancer; 2002 Sep; 95(5):1055-63. PubMed ID: 12209691
[TBL] [Abstract][Full Text] [Related]
11. [Expression of vascular endothelial growth factor and its receptor (Flt-1) in breast carcinoma].
Wu H; Li Y; Zhu G; Zhang L; Zhang X; He X
Zhonghua Yi Xue Za Zhi; 2002 May; 82(10):708-11. PubMed ID: 12133473
[TBL] [Abstract][Full Text] [Related]
12. Angiogenic co-operation of VEGF and stromal cell TP in endometrial carcinomas.
Sivridis E; Giatromanolaki A; Anastasiadis P; Georgiou L; Gatter KC; Harris AL; Bicknell R; Koukourakis MI;
J Pathol; 2002 Apr; 196(4):416-22. PubMed ID: 11920737
[TBL] [Abstract][Full Text] [Related]
13. The short form of the alternatively spliced flt-4 but not its ligand vascular endothelial growth factor C is related to lymph node metastasis in human breast cancers.
Gunningham SP; Currie MJ; Han C; Robinson BA; Scott PA; Harris AL; Fox SB
Clin Cancer Res; 2000 Nov; 6(11):4278-86. PubMed ID: 11106244
[TBL] [Abstract][Full Text] [Related]
14. The expression of vascular endothelial growth factor-A and -C, and receptors 1 and 3: correlation with lymph node metastasis and prognosis in tongue squamous cell carcinoma.
Tanigaki Y; Nagashima Y; Kitamura Y; Matsuda H; Mikami Y; Tsukuda M
Int J Mol Med; 2004 Sep; 14(3):389-95. PubMed ID: 15289890
[TBL] [Abstract][Full Text] [Related]
15. [Correlation between expression of vascular endothelial growth factor and prognosis of patients with esophageal squamous cell carcinoma].
Hu CZ; Wang YX; Zhang XZ
Ai Zheng; 2002 Mar; 21(3):301-4. PubMed ID: 12452000
[TBL] [Abstract][Full Text] [Related]
16. Expression of vascular endothelial growth factors (VEGF-A/VEGF-1 and VEGF-C/VEGF-2) in postmenopausal uterine endometrial carcinoma.
Hirai M; Nakagawara A; Oosaki T; Hayashi Y; Hirono M; Yoshihara T
Gynecol Oncol; 2001 Feb; 80(2):181-8. PubMed ID: 11161857
[TBL] [Abstract][Full Text] [Related]
17. Cytosol vascular endothelial growth factor in endometrial carcinoma: correlation with disease-free survival.
Chen CA; Cheng WF; Lee CN; Wei LH; Chu JS; Hsieh FJ; Hsieh CY
Gynecol Oncol; 2001 Feb; 80(2):207-12. PubMed ID: 11161861
[TBL] [Abstract][Full Text] [Related]
18. [Prognostic significance of VEGF receptors, VEGFR-1 (Flt-1) and VEGFR-2 (KDR/Flk-1) in breast carcinoma].
Dales JP; Garcia S; Bonnier P; Duffaud F; Carpentier S; Djemli A; Ramuz O; Andrac L; Lavaut M; Allasia C; Charpin C
Ann Pathol; 2003 Sep; 23(4):297-305. PubMed ID: 14597894
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor/KDR activated microvessel density versus CD31 standard microvessel density in non-small cell lung cancer.
Koukourakis MI; Giatromanolaki A; Thorpe PE; Brekken RA; Sivridis E; Kakolyris S; Georgoulias V; Gatter KC; Harris AL
Cancer Res; 2000 Jun; 60(11):3088-95. PubMed ID: 10850461
[TBL] [Abstract][Full Text] [Related]
20. [Expression of VEGF, bFGF and ER in endometrial carcinoma].
Bai X; Mi R
Zhonghua Zhong Liu Za Zhi; 2001 May; 23(3):211-3. PubMed ID: 11783088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
